IRCT20210914052480N3招募中2 期
Comparing the safety and efficacy of the Ursodeoxycolic acid (Cholicray) and Ursophar in Patients with fatty liver disease and biliary disorders
Reyhaneh Pharmaceutical Company0 个研究点目标入组 70 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 70
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 no limit（—）
- 性别
- All
入选标准
- •above 18 years old
- •Consent to participate in the study
- •Presence of liver or biliary disorders such as fatty liver, cholangitis, Primary biliary cirrhosis, Calculus of bile duct.
排除标准
- 未提供
研究者
相似试验
已完成
不适用
The evaluation of the effectiveness of Ursodeoxycholic acid for the self-expanded metallic stent in the distal malignant biliary obstruction case.JPRN-UMIN000046862Gifu Municipal Hospital120
已完成
4 期
efficacy of ursodeoxycholic plus phototherapy in the treatment of neonatal jaundiceIRCT201611163127N3Vice chancellor for research, Ardabil University of Medical Sciences100
招募中
3 期
Evaluating the therapeutic effect of ursodeoxycholic acid on the reduction of serum bilirubin in neonates with prolonged jaundiceeonatal jaundice.Neonatal jaundice from other and unspecified causesIRCT20180228038895N2Rasht University of Medical Sciences58
招募中
4 期
Investigation of the effect of oral ursodeoxycholic acid drug in neonatal jaundiceIRCT20130313012803N3Rasht University of Medical Sciences106
招募中
不适用
The efficacy of Ursodeoxycholic on faster improvement of patients with psoriasisPsoriasis.psoriasis vulgarisIRCT2017092536415N1Tehran University of Medical Sciences30